Advestra advised SIG Group on the placement of EUR 500 million bonds. The bonds in question, issued by SIG Combibloc PurchaseCo and guaranteed by SIG Group, have a coupon of 4.000% and will mature in 2031. BNP Paribas, BofA Securities, DZ Bank, HSBC and Coöperative Rabobank served as active bookrunners in the transaction. The Advestra […]
Niederer Kraft Frey (NKF) advised Swiss private banking group EFG International in connection with EFG Bank’s offering and issuance of new CHF 130 million senior unsecured bonds 2026 – 2032 and the concurrent first reopening for CHF 140 million
Kellerhals Carrard advised listed investment company RealUnit Schweiz throghout completion of its capital increase. The new bearer shares of RealUnit Schweiz, a Swiss investment company that invests in a portfolio of real assets and equities,
Homburger advised Nestlé in connection with the company’s issuance of USD 2 bn senior guaranteed notes, through an institutional offering in the United States. The operation comprised of USD 750 m in aggregate principal amount of 4.200%
Homburger advised UBS, acting through its Stamford branch, on its offering of USD 3.05 bn senior notes. The operation comprised of USD 500 m in aggregate principal amount of floating rate senior notes due 2029; USD 1.3 bn in
Advestra advised Swiss pharmaceutical company Novartis on all Swiss aspects of its USD 11.0 billion note placement. The notes in question were issued in seven tranches of which six were fixed rate notes while one tranche
Walder Wyss advised Nasdaq-listed CRISPR Therapeutics, as the Switzerland-based biopharmaceutical company issued a USD 600 million aggregate principal amount of convertible senior notes. The convertible senior notes were offered in a private offering to qualified institutional
Swiss dermatology specialist Galderma issued EUR 500 million bonds due 2031 with a coupon of 3.375%. In connection with the operation, Advestra represented Galderma, while Walder Wyss advised the banking syndicate, consisting of Citigroup, ING, RBC Capital Markets
Advestra advised Sandoz, a generic and biosimilar medicines specialist with headquarters in Basel, on its CHF 550 million bonds issuance. The issuance comprises a CHF 275 million tranche with a six-year maturity and a 1.1875% coupon, and a
Advestra advised Swiss Prime Site as the Swiss real estate company placed green convertible bonds in the total aggregate amount of CHF 350 million. The net proceeds from the issuance are expected to be used
